CD274 and cancer: In order to further verify the immunomodulatory effects of these genes in cancer patients, we downloaded RNA-seq data of 348 urothelial carcinoma patients (IMvigor210) who received anti-PD-L1 (Atezolizumab) treatment (Necchi et al., 2017).